These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 18838971)

  • 1. A diagnostic algorithm for the atherogenic apolipoprotein B dyslipoproteinemias.
    de Graaf J; Couture P; Sniderman A
    Nat Clin Pract Endocrinol Metab; 2008 Nov; 4(11):608-18. PubMed ID: 18838971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application and validation of a diagnostic algorithm for the atherogenic apoB dyslipoproteinemias: ApoB dyslipoproteinemias in a Dutch population-based study.
    Holewijn S; Sniderman AD; den Heijer M; Swinkels DW; Stalenhoef AF; de Graaf J
    Eur J Clin Invest; 2011 Apr; 41(4):423-33. PubMed ID: 21128932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis and treatment of apolipoprotein B dyslipoproteinemias.
    Sniderman A; Couture P; de Graaf J
    Nat Rev Endocrinol; 2010 Jun; 6(6):335-46. PubMed ID: 20421882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High prevalence of apolipoprotein B dyslipoproteinemias in non-alcoholic fatty liver disease: The lifelines cohort study.
    Nass KJ; van den Berg EH; Faber KN; Schreuder TCMA; Blokzijl H; Dullaart RPF
    Metabolism; 2017 Jul; 72():37-46. PubMed ID: 28641782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Applying apoB to the diagnosis and therapy of the atherogenic dyslipoproteinemias: a clinical diagnostic algorithm.
    Sniderman AD
    Curr Opin Lipidol; 2004 Aug; 15(4):433-8. PubMed ID: 15243216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atherogenic forms of dyslipidaemia in women with polycystic ovary syndrome.
    Berneis K; Rizzo M; Hersberger M; Rini GB; Di Fede G; Pepe I; Spinas GA; Carmina E
    Int J Clin Pract; 2009 Jan; 63(1):56-62. PubMed ID: 19125993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis of type III hyperlipoproteinemia from plasma total cholesterol, triglyceride, and apolipoprotein B.
    Sniderman A; Tremblay A; Bergeron J; Gagné C; Couture P
    J Clin Lipidol; 2007 Aug; 1(4):256-63. PubMed ID: 21291689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apolipoprotein B: the Rosetta Stone of lipidology.
    Glavinovic T; Sniderman AD
    Curr Opin Endocrinol Diabetes Obes; 2021 Apr; 28(2):90-96. PubMed ID: 33229928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Why measurement of apoB helps in the diagnosis and treatment of atherogenic dyslipoproteinemias.
    Sniderman A
    Can J Cardiol; 1991 May; 7(4):VII-VIII. PubMed ID: 2070282
    [No Abstract]   [Full Text] [Related]  

  • 10. Correlation of non-high-density lipoprotein cholesterol and low-density lipoprotein cholesterol with apolipoprotein B during simvastatin + fenofibrate therapy in patients with combined hyperlipidemia (a subanalysis of the SAFARI trial).
    Grundy SM; Vega GL; Tomassini JE; Tershakovec AM
    Am J Cardiol; 2009 Aug; 104(4):548-53. PubMed ID: 19660610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency of low-density lipoprotein receptor gene mutations in patients with a clinical diagnosis of familial combined hyperlipidemia in a clinical setting.
    Civeira F; Jarauta E; Cenarro A; García-Otín AL; Tejedor D; Zambón D; Mallen M; Ros E; Pocoví M
    J Am Coll Cardiol; 2008 Nov; 52(19):1546-53. PubMed ID: 19007590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship of oxidized phospholipids and biomarkers of oxidized low-density lipoprotein with cardiovascular risk factors, inflammatory biomarkers, and effect of statin therapy in patients with acute coronary syndromes: Results from the MIRACL (Myocardial Ischemia Reduction With Aggressive Cholesterol Lowering) trial.
    Fraley AE; Schwartz GG; Olsson AG; Kinlay S; Szarek M; Rifai N; Libby P; Ganz P; Witztum JL; Tsimikas S;
    J Am Coll Cardiol; 2009 Jun; 53(23):2186-96. PubMed ID: 19497447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apolipoprotein B versus LDL-cholesterol: Association with other risk factors for atherosclerosis.
    Vaverkova H; Karasek D; Novotny D; Jackuliakova D; Lukes J; Halenka M; Frohlich J
    Clin Biochem; 2009 Aug; 42(12):1246-51. PubMed ID: 19450572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atorvastatin affects low density lipoprotein and non-high density lipoprotein cholesterol relations with apolipoprotein B in type 2 diabetes mellitus: modification by triglycerides and cholesteryl ester transfer protein.
    Kappelle PJ; Zwang L; Huisman MV; Banga JD; Sluiter WJ; Dallinga-Thie GM; Dullaart RP
    Expert Opin Ther Targets; 2009 Jul; 13(7):743-51. PubMed ID: 19505224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic utility of apoB/AI, total cholesterol/HDL, non-HDL cholesterol, or hs-CRP as predictors of clinical risk in patients receiving statin therapy after acute coronary syndromes: results from PROVE IT-TIMI 22.
    Ray KK; Cannon CP; Cairns R; Morrow DA; Ridker PM; Braunwald E
    Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):424-30. PubMed ID: 19122170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of oxidized phospholipids in mediating lipoprotein(a) atherogenicity.
    Tsimikas S; Witztum JL
    Curr Opin Lipidol; 2008 Aug; 19(4):369-77. PubMed ID: 18607184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cryptogenic cirrhosis in a patient with familial hypocholesterolemia due to a new truncated form of apolipoprotein B.
    Bonnefont-Rousselot D; Condat B; Sassolas A; Chebel S; Bittar R; Federspiel MC; Cazals-Hatem D; Bruckert E
    Eur J Gastroenterol Hepatol; 2009 Jan; 21(1):104-8. PubMed ID: 19060634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conventional lipid profile and lipoprotein(a) concentrations in treated patients with rheumatoid arthritis.
    García-Gómez C; Nolla JM; Valverde J; Gómez-Gerique JA; Castro MJ; Pintó X
    J Rheumatol; 2009 Jul; 36(7):1365-70. PubMed ID: 19369465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid profile, apolipoproteins A and B in children with epilepsy.
    Tomoum HY; Awadallah MM; Fouad DA; Ali AH
    J Child Neurol; 2008 Nov; 23(11):1275-81. PubMed ID: 18984836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targets for LDL-lowering therapy.
    Sniderman A
    Curr Opin Lipidol; 2009 Aug; 20(4):282-7. PubMed ID: 19474729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.